Biblio
“Urine AD7c-NTP Predicts Amyloid Deposition and Symptom of Agitation in Patients with Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 60, no. 1, pp. 87-95, 2017.
, “Urine Formaldehyde Predicts Cognitive Impairment in Post-Stroke Dementia and Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1031-1038, 2017.
, “Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods.”, J Alzheimers Dis, vol. 65, no. 2, pp. 421-431, 2018.
, “Use of Analgesics (Opioids and Nonsteroidal Anti-Inflammatory Drugs) and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.”, J Alzheimers Dis, vol. 58, no. 2, pp. 435-448, 2017.
, “Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 75, no. 1, pp. 23-43, 2020.
, “The Use of Mobile Games to Assess Cognitive Function of Elderly with and without Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1285-1293, 2018.
, “The Use of Music Playlists for People with Dementia: A Critical Synthesis.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1129-1142, 2017.
, “Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).”, J Alzheimers Dis, vol. 50, no. 1, pp. 61-70, 2016.
, “Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 765-779, 2018.
, “Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 56, no. 2, pp. 677-686, 2017.
, “Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.”, J Alzheimers Dis, vol. 75, no. 1, pp. 277-288, 2020.
, “Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 195-204, 2018.
, “Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1025-1033, 2018.
, “Utility of Amyloid PET Scans in the Evaluation of Patients Presenting with Diverse Cognitive Complaints.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1599-1608, 2018.
, “Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1193-1211, 2018.
, “Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 77, no. 4, pp. 1545-1558, 2020.
, “Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.”, J Alzheimers Dis, vol. 60, no. 3, pp. 939-947, 2017.
, “The Utility of the Cognitive Function Instrument (CFI) to Detect Cognitive Decline in Non-Demented Older Adults.”, J Alzheimers Dis, vol. 60, no. 2, pp. 427-437, 2017.
, “Utility of the LIBRA Index in Relation to Cognitive Functioning in a Clinical Health Seeking Sample.”, J Alzheimers Dis, vol. 62, no. 1, pp. 373-384, 2018.
, “The Utilization of Retinal Nerve Fiber Layer Thickness to Predict Cognitive Deterioration.”, J Alzheimers Dis, vol. 49, no. 2, pp. 399-405, 2016.
, “The Utilization of Robotic Pets in Dementia Care.”, J Alzheimers Dis, vol. 55, no. 2, pp. 569-574, 2017.
, “Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.”, J Alzheimers Dis, vol. 98, no. 2, pp. 343-360, 2024.
, “Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.”, J Alzheimers Dis, vol. 98, no. 2, pp. 361-372, 2024.
, “Vacuolar Protein-Sorting Proteins Are Reduced Even Before Cognitive Decline in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 3, pp. 1011-1017, 2023.
, “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
,